Skip to main content
. 2020 Nov 11;60(5):2206–2216. doi: 10.1093/rheumatology/keaa544

Table 1.

Baseline characteristics

OA patients (n = 164 292) OA patients without comorbidities1 (n = 99 099)
Age, mean (s.d.), years 66.6 (12.4) 66.4 (12.3)
Age category, n (%)
 30–39 2637 (1.6) 1730 (1.7)
 40–49 12007 (7.3) 7246 (7.3)
 50–59 32 786 (20.0) 19 276 (19.5)
 60–69 48 756 (29.7) 30 156 (30.4)
 70–79 40 749 (24.8) 25 195 (25.4)
 80–89 23 639 (14.4) 13 543 (13.7)
 ≥90 3718 (2.3) 1953 (2.0)
Female, n (%) 107 438 (65.2) 60 720 (61.3)
Joints affected, n (%)
 Spine 17 243 (10.5) 10 180 (10.3)
 Hip 27 762 (16.9) 18 075 (18.2)
 Knee 45 064 (27.4) 28 610 (28.9)
 Other joints 37 753 (23.0) 22 189 (22.4)
 2 or more joints 36 470 (22.2) 20 045 (20.2)
Comorbidities
 Diabetes, n (%) 25 175 (15.3) 13 608 (13.7)
 Hypertension, n (%) 66 866 (40.7) 38 005 (38.4)
 Hyperlipidaemia, n (%) 29 224 (17.8) 15 497 (15.6)
 MI/AP, n (%) 18 868 (11.5) 9674 (9.8)
 Stroke/TIA, n (%) 6352 (3.9) 3114 (3.1)
 PAD, n (%) 6365 (3.9) 3096 (3.1)
 UGI/ulcer, n (%) 5723 (3.5) 2753 (2.8)
 Heart failure, n (%) 6989 (4.3) 3374 (3.4)
 Inflammatory arthritis, n (%) 7949 (4.8) 4122 (4.2)
 Fibromyalgia, n (%) 2492 (1.5) NA
 Neuropathic pain disorder, n (%) 19 202 (11.7) NA
 Depression, n (%) 28 714 (17.5) NA
 Anxiety, n (%) 27 397 (16.7) NA
 Psychosis, n (%) 4084 (2.5) NA
 Sleeping disorder, n (%) 32 278 (19.6) NA
 Epilepsy, n (%) 2404 (1.5) NA
Other MSD during cohort time, n (%)
 Upper extremity 39 061 (23.8) 21 702 (21.9)
 Lower extremity 61 076 (37.2) 34 485 (34.8)
 Back/neck 51 260 (31.2) 28 105 (28.4)
 Other musculoskeletal 50 559 (30.8) 27 486 (27.7)
 None 57 609 (35.1) 37 903 (38.2)
Renal function, n (%)
 eGFR>60 ml/min 103 952 (63.3) 59 613 (60.2)
 eGFR 30–60 ml/min 19 382 (11.8) 10 794 (10.9)
 eGFR<30 ml/min 1614 (1.0) 896 (0.9)
 Missing 39 344 (23.9) 27 796 (28.0)

MI: myocardial infarction; AP: angina pectoris; TIA: transient ischemic attack; PAD: peripheral arterial disease; UGI: upper gastro-intestinal; MSD: musculoskeletal disorder; eGFR: estimated glomerular filtration rate.